Cristina Abrahams

Title: Cristina Abrahams: Innovator in Antibody Conjugate Technologies

Introduction

Cristina Abrahams is a prominent inventor based in Burlingame, CA, known for her significant contributions to the field of antibody conjugates. With a total of seven patents to her name, she has made remarkable advancements in therapeutic and diagnostic methods.

Latest Patents

Her latest patents include innovative developments such as anti-folate receptor antibody conjugates and anti-ROR1 antibody conjugates. The anti-folate receptor antibody conjugates focus on binding specificity for folate receptor alpha (FOLR1) and its isoforms, providing compositions that include pharmaceutical applications. Additionally, her work on anti-ROR1 antibody conjugates emphasizes the binding specificity for receptor tyrosine kinase orphan receptor 1 (ROR1), further enhancing the potential for therapeutic and diagnostic uses.

Career Highlights

Cristina has worked with notable companies in the biotechnology sector, including Sutro Biopharma, Inc. and Merck Sharp & Dohme Corporation. Her experience in these organizations has allowed her to refine her expertise in antibody technologies and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Ryan Stafford and Alice Yam, who have collaborated with her on various projects, enhancing the innovation landscape in their field.

Conclusion

Cristina Abrahams stands out as a leading inventor in the realm of antibody conjugate technologies, with a strong portfolio of patents that reflect her dedication to advancing medical science. Her work continues to influence therapeutic and diagnostic methods, showcasing her impact on the industry.